Health
BioNTech, Pfizer file for EU approval of COVID-19 vaccine – CGTN
On Tuesday, Germany’s BioNTech and its U.S. partner Pfizer said they had applied for EU regulatory approval for their COVID-19 vaccine, raising hopes that the first jabs could be administered in December.
The two companies said in a statement that they had submitted an application to the European Medicines Agency on Monday “for Conditional Marketing Authorization (CMA)” for their vaccine after tests showed it was 95 percent effective against the novel coronavirus.
If approved, the jab could potentially…
Continue Reading
-
Noosa News23 hours agoDisaster relief packages announced for flood-stricken western Queensland
-
General18 hours agoIran’s currency at record low as tensions run high
-
General17 hours agoLabor to pledge $2.3 billion to subsidise home batteries
-
General23 hours ago307,000 Voices | The Spectator Australia